Akero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street
Akero Therapeutics, Inc. (NASDAQ:AKRO) is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on developing…
Browsing Tag